Skip to content
2000
Volume 3, Issue 2
  • ISSN: 0250-6882
  • E-ISSN: 0250-6882

Abstract

Objectives

Pertussis seroprotection among neonates depends on maternal antibodies before receiving their first childhood acellular pertussis (DTaP) vaccination. Therefore, childbearing women need to have adequate seroprotection, either before conception or during the antenatal period, to protect their neonates from contracting neonatal pertussis. Given the global rise in neonatal pertussis incidence, there is a need to address the importance of protection against this infection by promoting booster vaccinations among female medical students as a preventive measure for their future generation. This paper addresses a part of our study on the seroprevalence of anti-PT IgG antibodies in female medical students who are more prone to acquire infections from the patients during their clinical rotations.

Methods

A cross-sectional study was conducted for three months by recruiting female medical students of RAK Medical and Health Sciences University, Ras Al Khaimah, UAE. The antibody levels (IgG) of pertussis (anti-PT) in blood sera of the study population were quantitated by enzyme-linked immunoassay. A 60 – 125 IU/mL titer was considered the positive titer level (p-value <0.05 being statistically significant).

Results

Among 90 ethnically different student participants (mean age of 21 years), forty-four percent (n=40) showed detectable titers of anti-PT IgG antibodies. Whereas fourteen percent of participants (n=13) had high positive titers above 125U/mL, four percent (n=3) showed positive titers ranging from 60-125IU/mL. Two percent (n=2) were in borderline with 55 - <60IU/mL and twenty three percent (n=21) were < 55IU/mL titres. The mean ± SD of IgG titers was 42 ± 74.93 IU/mL with a range of 0-267 IU/mL

Conclusion

Only forty-four percent had detectable titers of anti-PT IgG antibodies, among whom fourteen percent (n=13) had high positive titers indicating recent infection. The results signify a low level of seroprotection among female medical students that emphasizes the need to promote booster vaccination for the high-risk group who work in the health profession.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/nemj/10.2174/03666220816103424
2022-09-01
2025-01-19
Loading full text...

Full text loading...

/deliver/fulltext/nemj/3/2/NEMJ-3-2-08.html?itemId=/content/journals/nemj/10.2174/03666220816103424&mimeType=html&fmt=ahah

References

  1. MelvinJ.A. SchellerE.V. MillerJ.F. CotterP.A. Bordetella pertussis pathogenesis: Current and future challenges.Nat. Rev. Microbiol.201412427428810.1038/nrmicro323524608338
    [Google Scholar]
  2. GreenbergD.P. von KönigC.H.W. HeiningerU. Health burden of pertussis in infants and children.Pediatr. Infect. Dis. J.2005245Suppl.S39S4310.1097/01.inf.0000160911.65632.e115876922
    [Google Scholar]
  3. Pertussis vaccines: WHO position paper - September 2015.Wkly. Epidemiol. Rec.2015903543345826320265
    [Google Scholar]
  4. CDCCoronavirus Disease 2019 (COVID-19). Centres for Disease Control and Prevention.2020https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html
    [Google Scholar]
  5. WoodN. McIntyreP. Pertussis: Review of epidemiology, diagnosis, management and prevention.Paediatr. Respir. Rev.20089320121210.1016/j.prrv.2008.05.01018694712
    [Google Scholar]
  6. BaxterR. BartlettJ. FiremanB. LewisE. KleinN.P. Effectiveness of vaccination during pregnancy to prevent infant pertussis.Pediatrics20171395e2016409110.1542/peds.2016‑409128557752
    [Google Scholar]
  7. NooitgedagtJ.E. de GreeffS.C. ElversB.H. de MelkerH.E. NotermansD.W. van HuisselingH. VersteeghF.G.A. Seroprevalence of Bordetella pertussis infection during pregnancy measured by IgG antibodies against pertussis toxin.Clin. Infect. Dis.20094971086108910.1086/60557519725791
    [Google Scholar]
  8. StorsaeterJ. HallanderH.O. GustafssonL. OlinP. Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis.Vaccine20032125-263542354910.1016/S0264‑410X(03)00407‑912922081
    [Google Scholar]
  9. Van RieA. WendelboeA.M. EnglundJ.A. Role of maternal pertussis antibodies in infants.Pediatr. Infect. Dis. J.2005245Suppl.S62S6510.1097/01.inf.0000160915.93979.8f15876928
    [Google Scholar]
  10. HealyC.M. RenchM.A. BakerC.J. Implementation of cocooning against pertussis in a high-risk population.Clin. Infect. Dis.201152215716210.1093/cid/ciq00121288837
    [Google Scholar]
  11. CroweJ.E. CHAPTER 38 - Prevention of Fetal and Early Life Infections Through Maternal–Neonatal Immunization. In: Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado YA, eds.Infectious Diseases of the Fetus and Newborn (Seventh Edition)20111212123010.1016/B978‑1‑4160‑6400‑8.00038‑9
    [Google Scholar]
  12. BlackS. Epidemiology of pertussis.Pediatr. Infect. Dis. J.1997164Suppl.S85S8910.1097/00006454‑199704001‑000039109162
    [Google Scholar]
  13. HashemiS.H. RanjbarM. HajilooiM. Seif-RabieiM.A. BolandiM. MoghimiJ. Seroprevalence of Immunoglobulin G antibodies against pertussis toxin among asymptomatic medical students in the west of Iran: A cross sectional study.BMC Infect. Dis.2009915810.1186/1471‑2334‑9‑5819426546
    [Google Scholar]
  14. Arav-BogerR. AshkenaziS. GdalevichM. CohenD. DanonY.L. Seroprevalence of pertussis antibodies among adolescents in Israel.Isr. Med. Assoc. J.20002217417710804947
    [Google Scholar]
  15. MinkC.M. CherryJ.D. ChristensonP. LewisK. PinedaE. ShlianD. DawsonJ.A. BlumbergD.A. A search for Bordetella pertussis infection in university students.Clin. Infect. Dis.199214246447110.1093/clinids/14.2.4641554832
    [Google Scholar]
  16. NarchiH. OsmanW. GeorgeJ.A. AlmekhainiL.A. SouidA.K. AlsuwaidiA.R. Pertussis seronegativity in pregnant women in the city of Al Ain, United Arab Emirates.Int. J. Infect. Dis.2019899610110.1016/j.ijid.2019.08.03131493522
    [Google Scholar]
  17. HashemiS.H. ZamaniM. MamaniM. JavedanpoorR. RahighiA.H. NadiE. Seroprevalence of Bordetella pertussis antibody in pregnant women in Iran.J. Res. Health Sci.201414212813124728747
    [Google Scholar]
  18. WendelboeA.M. Van RieA. SalmasoS. EnglundJ.A. Duration of immunity against pertussis after natural infection or vaccination.Pediatr. Infect. Dis. J.2005245Suppl.S58S6110.1097/01.inf.0000160914.59160.4115876927
    [Google Scholar]
  19. MazzilliS. TavoschiL. LopalcoP.L. Tdap vaccination during pregnancy to protect newborns from pertussis infection.Ann. Ig.201830434636310.7416/ai.2018.222629895052
    [Google Scholar]
  20. SedighiI SadrosadatT. Comment on: Seroprevalence of Bordetella pertussis Antibody in Pregnant Women in Iran.J Resn Health Sci2014143236237
    [Google Scholar]
  21. WangC.Q. ZhuQ.R. Seroprevalence of Bordetella pertussis antibody in children and adolescents in China.Pediatr. Infect. Dis. J.201130759359610.1097/INF.0b013e31820eaf8821422963
    [Google Scholar]
  22. Rendi-WagnerP. TobiasJ. MoermanL. GorenS. BassalR. GreenM. CohenD. The seroepidemiology of Bordetella pertussis in Israel—Estimate of incidence of infection.Vaccine201028193285329010.1016/j.vaccine.2010.02.10420226250
    [Google Scholar]
  23. ZhangQ. ZhengH. LiuM. HanK. ShuJ. WuC. XuN. HeQ. LuoH. The seroepidemiology of Immunoglobulin G antibodies against pertussis toxin in China: A cross sectional study.BMC Infect. Dis.201212113810.1186/1471‑2334‑12‑13822892100
    [Google Scholar]
  24. WanlapakornN. NgaovithunvongV. ThongmeeT. VichaiwattanaP. VongpunsawadS. PoovorawanY. Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination.PLoS One2016112e014833810.1371/journal.pone.014833826837004
    [Google Scholar]
  25. LiangJ.L. TiwariT. MoroP. MessonnierN.E. ReingoldA. SawyerM. ClarkT.A. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm. Rep.201867214410.15585/mmwr.rr6702a129702631
    [Google Scholar]
  26. ZhangL. PrietschS.O.M. AxelssonI. HalperinS.A. Acellular vaccines for preventing whooping cough in children.Cochrane Libr.20149CD00147810.1002/14651858.CD001478.pub625228233
    [Google Scholar]
  27. EberhardtC.S. Blanchard-RohnerG. LemaîtreB. BoukridM. CombescureC. Othenin-GirardV. ChilinA. PetreJ. de TejadaB.M. SiegristC.A. Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis.Clin. Infect. Dis.201662782983610.1093/cid/ciw02726797213
    [Google Scholar]
  28. SwamyG.K. WheelerS.M. Neonatal pertussis, cocooning and maternal immunization.Expert Rev. Vaccines20141391107111410.1586/14760584.2014.94450925075629
    [Google Scholar]
/content/journals/nemj/10.2174/03666220816103424
Loading
/content/journals/nemj/10.2174/03666220816103424
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keyword(s): Antibodies; DTP; Immunization; Neonate; Pertussis seroprotection; Seroprevalence
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test